The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thyroid Gland Disorders Treatment Market Research Report 2025
Synopsis
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to the thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When the thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, the body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
This report aims to provide a comprehensive presentation of the global market for Thyroid Gland Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Gland Disorders Treatment.
Report Scope
The Thyroid Gland Disorders Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Gland Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Gland Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Merck KGaA
Lannett Company
Mylan
Allergan
Pfizer
Novartis
GlaxoSmithKline
Abbott Laboratories
Sanofi
Segment by Type
Hypothyroidism
Hyperthyroidism
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Gland Disorders Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to the thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When the thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, the body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
This report aims to provide a comprehensive presentation of the global market for Thyroid Gland Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Gland Disorders Treatment.
Report Scope
The Thyroid Gland Disorders Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Gland Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Gland Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Merck KGaA
Lannett Company
Mylan
Allergan
Pfizer
Novartis
GlaxoSmithKline
Abbott Laboratories
Sanofi
Segment by Type
Hypothyroidism
Hyperthyroidism
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Gland Disorders Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Gland Disorders Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hypothyroidism
1.2.3 Hyperthyroidism
1.3 Market by Application
1.3.1 Global Thyroid Gland Disorders Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Gland Disorders Treatment Market Perspective (2019-2030)
2.2 Thyroid Gland Disorders Treatment Growth Trends by Region
2.2.1 Global Thyroid Gland Disorders Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Thyroid Gland Disorders Treatment Historic Market Size by Region (2019-2024)
2.2.3 Thyroid Gland Disorders Treatment Forecasted Market Size by Region (2025-2030)
2.3 Thyroid Gland Disorders Treatment Market Dynamics
2.3.1 Thyroid Gland Disorders Treatment Industry Trends
2.3.2 Thyroid Gland Disorders Treatment Market Drivers
2.3.3 Thyroid Gland Disorders Treatment Market Challenges
2.3.4 Thyroid Gland Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Gland Disorders Treatment Players by Revenue
3.1.1 Global Top Thyroid Gland Disorders Treatment Players by Revenue (2019-2024)
3.1.2 Global Thyroid Gland Disorders Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Thyroid Gland Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Gland Disorders Treatment Revenue
3.4 Global Thyroid Gland Disorders Treatment Market Concentration Ratio
3.4.1 Global Thyroid Gland Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Gland Disorders Treatment Revenue in 2023
3.5 Thyroid Gland Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Thyroid Gland Disorders Treatment Product Solution and Service
3.7 Date of Enter into Thyroid Gland Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Gland Disorders Treatment Breakdown Data by Type
4.1 Global Thyroid Gland Disorders Treatment Historic Market Size by Type (2019-2024)
4.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Type (2025-2030)
5 Thyroid Gland Disorders Treatment Breakdown Data by Application
5.1 Global Thyroid Gland Disorders Treatment Historic Market Size by Application (2019-2024)
5.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Thyroid Gland Disorders Treatment Market Size (2019-2030)
6.2 North America Thyroid Gland Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Thyroid Gland Disorders Treatment Market Size by Country (2019-2024)
6.4 North America Thyroid Gland Disorders Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Gland Disorders Treatment Market Size (2019-2030)
7.2 Europe Thyroid Gland Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Thyroid Gland Disorders Treatment Market Size by Country (2019-2024)
7.4 Europe Thyroid Gland Disorders Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Gland Disorders Treatment Market Size (2019-2030)
8.2 Asia-Pacific Thyroid Gland Disorders Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Thyroid Gland Disorders Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Thyroid Gland Disorders Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Gland Disorders Treatment Market Size (2019-2030)
9.2 Latin America Thyroid Gland Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Thyroid Gland Disorders Treatment Market Size by Country (2019-2024)
9.4 Latin America Thyroid Gland Disorders Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Gland Disorders Treatment Market Size (2019-2030)
10.2 Middle East & Africa Thyroid Gland Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Thyroid Gland Disorders Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Thyroid Gland Disorders Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Thyroid Gland Disorders Treatment Introduction
11.1.4 AbbVie Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Thyroid Gland Disorders Treatment Introduction
11.2.4 Merck KGaA Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.2.5 Merck KGaA Recent Development
11.3 Lannett Company
11.3.1 Lannett Company Company Detail
11.3.2 Lannett Company Business Overview
11.3.3 Lannett Company Thyroid Gland Disorders Treatment Introduction
11.3.4 Lannett Company Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.3.5 Lannett Company Recent Development
11.4 Mylan
11.4.1 Mylan Company Detail
11.4.2 Mylan Business Overview
11.4.3 Mylan Thyroid Gland Disorders Treatment Introduction
11.4.4 Mylan Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.4.5 Mylan Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Thyroid Gland Disorders Treatment Introduction
11.5.4 Allergan Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.5.5 Allergan Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Thyroid Gland Disorders Treatment Introduction
11.6.4 Pfizer Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Thyroid Gland Disorders Treatment Introduction
11.7.4 Novartis Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Thyroid Gland Disorders Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.9.5 Abbott Laboratories Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Thyroid Gland Disorders Treatment Introduction
11.10.4 Sanofi Revenue in Thyroid Gland Disorders Treatment Business (2019-2024)
11.10.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
